2020
DOI: 10.1158/0008-5472.can-19-3613
|View full text |Cite
|
Sign up to set email alerts
|

HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma

Abstract: Activation of oncogenic KRAS is the most common driving event in lung adenocarcinoma development. Despite the existing rationale for targeting activated KRAS and its downstream effectors, the failure of clinical trials to date indicates that the mechanism of KRAS-driven malignancy remains poorly understood. Here we report that histone deacetylase 10 (HDAC10) might function as a putative tumor suppressor in mice carrying a spontaneously activated oncogenic Kras allele. Hdac10 deletion accelerated KRAS-driven ea… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
35
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(38 citation statements)
references
References 65 publications
3
35
0
Order By: Relevance
“…By contrast, HDAC10 exhibits a potential TSG role by downregulating Sry-box transcription factor 9 (SOX9) in KRAS-driven lung adenocarcinoma. Furthermore, HDAC10 deficiency results in TGF-β pathway activation, leading to the induction of SOX9 and KRAS-expressing stem-like tumor growth (Li et al, 2020). Cancer-associated fibroblasts (CAFs) secrete extracellular matrix (ECM) that assists tumor progression and invasion.…”
Section: Epithelial-mesenchymal Transition Cancer Stem Cells and Sementioning
confidence: 99%
“…By contrast, HDAC10 exhibits a potential TSG role by downregulating Sry-box transcription factor 9 (SOX9) in KRAS-driven lung adenocarcinoma. Furthermore, HDAC10 deficiency results in TGF-β pathway activation, leading to the induction of SOX9 and KRAS-expressing stem-like tumor growth (Li et al, 2020). Cancer-associated fibroblasts (CAFs) secrete extracellular matrix (ECM) that assists tumor progression and invasion.…”
Section: Epithelial-mesenchymal Transition Cancer Stem Cells and Sementioning
confidence: 99%
“…Specifically, by activating the transforming growth-factor β (TGF-β) pathway, deletion of HDAC10 promotes the expression of SOX9, which subsequently upregulates the expression of SLUG, as well as CD44. These processes contributes to the growth of lung cancer spheres via sex determining region Y box protein 9 (SOX9)-mediated stem-like properties, suggesting that HDAC10-TGF-β-SOX9-SLUG/ CD44 axis plays an essential role in lung adenocarcinoma (30). AMP-activated protein kinase (AMPK) regulates biological functions in tumors that are mediated by liver kinase B1 (LKB1), such as cell survival and transcription, via the mTOR Downloaded from http://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20210462/911205/bsr-2021-0462.pdf by guest on 24 May 2021 pathway (33).…”
Section: Hdac10 and Cell Proliferationmentioning
confidence: 99%
“…It has been demonstrated that it can prompt cell proliferation in non-small-cell lung cancer (NSCLC) [ 29 ]. In contrast, HDAC10 suppresses cancer cell growth in other malignant tumors, including lung adenocarcinoma [ 30 ] and renal cell carcinoma (RCC) [ 31 ]. Akt is a key molecule in the PI3K-AKT pathway, and is involved in cell proliferation, survival and other key functions [ 32 ].…”
Section: Biological Characterization and Mechanism Of Hdac10 In Tumorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Importantly, HDAC2-deficient colon cancer cells are highly refractory to the apoptosis induced by HDAC inhibitors. Aberrations in other classes of HDACs are also associated with CSC function and tumor stratification [ 55 , 57 ]. Sirtuins are a particular type of HDACs, the function of which is to influence extension of lifespan (longevity).…”
Section: Aberrant Protein Acetylation In the Phenotypes Of Cancer Cellsmentioning
confidence: 99%